Next Article in Journal
Irritable Bowel Syndrome and Neurological Deficiencies: Is There A Relationship? The Possible Relevance of the Oxidative Stress Status
Next Article in Special Issue
Non-Clinical Variables Influencing Cesarean Section Rate According to Robson Classification
Previous Article in Journal
Liver Remodeling on CT Examination in Patients with HCV Compensated Cirrhosis Who Achieved Sustained Virological Response after Direct-Acting Antivirals Treatment
Previous Article in Special Issue
Body of Evidence in Favor of Adopting 130/80 mm Hg as New Blood Pressure Cut-Off for All the Hypertensive Disorders of Pregnancy
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Risk Factors for Neonatal/Maternal Morbidity and Mortality in African American Women with Placental Abruption

1
Department of Obstetrics and Gynecology, St. Joseph’s Regional Medical Center, Paterson, NJ 07503, USA
2
Department of Obstetrics and Gynecology, New York Health and Hospitals/Lincoln, Bronx, NY 10451, USA
3
Department of Obstetrics and Gynecology, University of Mississippi Medical Center, Jackson, MI 39216, USA
*
Author to whom correspondence should be addressed.
Medicina 2020, 56(4), 174; https://doi.org/10.3390/medicina56040174
Submission received: 10 March 2020 / Revised: 30 March 2020 / Accepted: 9 April 2020 / Published: 13 April 2020
(This article belongs to the Special Issue Pregnancy: Diagnosis, Misdiagnosis, Complications and Outcomes)

Abstract

:
Background and Objectives: Risk factors for neonatal/maternal morbidity and mortality in placental abruption have been incompletely studied in the current literature. Most of the research overlooked the African American population as mostly Caucasian populations are selected. We aimed to find which risk factor influence the neonatal and maternal outcome in cases of placental abruption occurring in African American pregnant women in an inner-city urban setting. Materials and Methods: We performed a retrospective cohort study at St. Joseph’s Regional Medical Center, NJ United States of America (USA), between 1986 and 1996. Inclusion criteria were African American race, singleton pregnancy with gestational age over 20 weeks and placental abruption. Maternal age, gravidity, parity, gestational age at delivery/occurrence of placental abruption and mode of delivery were collected. Risk factors for placental abruption such as placenta previa, hypertensive disorders of pregnancy, cigarette smoking, crack/cocaine and alcohol use, mechanical trauma, preterm premature rupture of membranes (PPROM), and premature rupture of membranes (PROM) were recorded. Poor neonatal outcome was considered when anyone of the following occurred: 1st and 5th minute Apgar score lower than 7, intrauterine fetal demise (IUFD), perinatal death, and neonatal arterial umbilical cord pH less than 7.15. Poor maternal outcome was considered if any of the following presented at delivery: hemorrhagic shock, disseminated intravascular coagulation (DIC), hysterectomy, postpartum hemorrhage (PPH), maternal intensive care unit (ICU) admission, and maternal death. Results: A population of 271 singleton African American pregnant women was included in the study. Lower gestational age at delivery and cesarean section were statistically significantly correlated with poor neonatal outcomes (p = 0.018; p < 0.001; p = 0.015) in the univariate analysis; only lower gestational age at delivery remained significant in the multivariate analysis (p = < 0.001). Crack/cocaine use was statistically significantly associated with poor maternal outcome (p = 0.033) in the univariate analysis, while in the multivariate analysis, hemolysis, elevated enzymes, low platelet (HELLP) syndrome, crack/cocaine use and previous cesarean section resulted significantly associated with poor maternal outcome (p = 0.029, p = 0.017, p = 0.015, p = 0.047). PROM was associated with better neonatal outcome in the univariate analysis, and preeclampsia was associated with a better maternal outcome in the multivariate analysis. Conclusions: Lower gestational age at delivery is the most important risk factor for poor neonatal outcome in African American women with placental abruption. Poor maternal outcome correlated with HELLP syndrome, crack/cocaine use and previous cesarean section. More research in this understudied population is needed to establish reliable risk factors and coordinate preventive interventions.

1. Introduction

Placental abruption is the premature separation of the placenta before birth, after 20 weeks of gestation [1]. In the United States of America (USA), clinically detected placental abruption increased by approximately 25 percent in the past decades and a significant increase was noted amongst African American women [2,3]. Placental abruption is a leading cause of maternal and neonatal morbidity and mortality [4,5]. Maternal complications include hemorrhage, disseminated intravascular coagulation (DIC), and hemorrhagic shock. Placental abruption causing fetal death occurs in approximately 1 of every 420 deliveries [1]; additionally, the majority of pregnancies complicated by abruption result in infants weighing less than 10th percentile for gestational age [6,7,8]. While the exact etiology of placental abruption is not well-defined in the literature, a plethora of associated risk factors have been established [8,9]. The most important risk factor for placental abruption is an abruption in a prior pregnancy [10,11,12,13]. Chronic hypertension is a pertinent risk factor for abruption—it is associated with a fivefold increase in risk, which rises to eightfold with superimposed preeclampsia [14]. Placental abruption is 2.5 times more likely to happen in cigarette smokers than non-smokers [15,16,17,18].
Even if the rate of placental abruption is increasing in African American women, they have been neglected by the majority of the research in the current literature, which mostly includes Caucasian women.
In this retrospective study, we evaluated the correlation between various risk factors of placental abruption and neonatal/maternal morbidity and mortality in African American women in an inner-city urban setting.
We described the risks factors and demographics of our population and then measured the association between risk factors and neonatal and maternal outcome.

2. Materials and Methods

We performed a retrospective cohort study of all cases of African American patients with placental abruption at St. Joseph’s Regional Medical Center, NJ (USA), between 1986 and 1996. The Institutional Review Board (IRB) approved this study on March 10, 2017, the approval number is 92019j.
The diagnosis of placental abruption was based on clinical findings of abdominal pain, vaginal bleeding, uterine contractions, fetal distress and vital sign abnormalities. We excluded women with multiple gestation and gestational age less than 20 weeks.
We decided to include every case from 20 weeks because the definition of placental abruption is possible at a gestational age > 20 weeks [19] and the lower gestational age limit for viability is still uncertain, indeed between 20 and 25 weeks there is a gray area with up to 50% of survival rate [20].
Age, gravidity, parity, and gestational age at diagnosis/delivery were collected for all patients. Gestational age was calculated using the last menstrual period and confirmed by an obstetric ultrasound in the first trimester, according to the American College of Obstetrics and Gynecology (ACOG) guidelines [21]. Risk factors associated with placental abruption such as mechanical trauma, preterm premature rupture of membranes (PPROM), premature rupture of membranes (PROM), chronic hypertension, preeclampsia, eclampsia, hemolysis, elevated liver enzymes, low platelet (HELLP) syndrome, placenta previa, mode of delivery, history of previous cesarean section, intrauterine growth retardation (IUGR), gestational diabetes mellitus (GDM), pre-GDM, smoking, alcohol, and crack/cocaine usage were recorded. The use of alcohol and crack/cocaine was documented by urine toxicology exam at admission. We considered as main outcome the occurrence of poor neonatal and maternal outcome. A composite poor neonatal outcome was considered present if any of the following was present: neonatal arterial umbilical cord pH at birth lower than 7.15, intrauterine fetal demise (IUFD), perinatal death, Apgar score lower than 7 at 1st and 5th minute of life. A composite poor maternal outcome was considered present if any of the following was present: hemorrhagic shock, disseminated intrauterine coagulation (DIC), hysterectomy, postpartum hemorrhage (PPH) (defined as estimated blood loss of more than 1000 mL according to the ACOG guidelines [22]), maternal intensive care unit (ICU) admission, maternal death. Statistical analysis was performed with the software SPSS (v. 26 IBM, Chicago, US). Normality of the continuous variables was checked with the Skewness and Kurtosis normality test. All the continuous variables resulted not-normally distributed. The Mann–Whitney test was used to compare patients with poor neonatal/maternal outcomes to patients with good neonatal/maternal outcomes. Chi square test was used for categorical variables. Receiver operating characteristic (ROC) curve analysis was used to estimate the association between continuous variable and the dichotomic outcome and the area under the curve (AUC) was calculated accordingly. The Youden index was used to establish the cut-off value for the continuous variables associated with the dichotomic outcome. A p-value of < 0.05 was considered statistically significant.

3. Results

Our initial population included 748 pregnant African American women who had placental abruption; however, 477 were excluded due to incomplete perinatal outcome data. Our final sample size was 271 pregnant women with placental abruption: 211 of 271 were preterm deliveries (gestational age less than 37 weeks) (77.8%) and 60 of 271 were term deliveries (gestational age more than 37 weeks) (22.1%).

3.1. Risk Factors

Sixteen of 271 pregnant patients with placental abruption had HELLP syndrome (5.90%), 76 of 271 had preeclampsia (28.0%), 22 of 271 had chronic hypertension (8.11%) and 4 of 271 had eclampsia (1.48%). Eighty of 271 had PROM (29.5%). Four of 271 patients had a mechanical trauma as a cause of placental abruption (1.48%), 40 of 271 had crack/cocaine use as a risk factor (14.7%), 53 of 271 smoked less than 10 cigarettes a day (19.5%), 51 of 271 smoked more than 10 cigarettes a day (18.8%), and 45 of 271 had alcohol use (16.6%). Nine of 271 pregnant women with placental abruption had placenta previa (3.32%).

3.2. Fetal Complications and Prognosis

One hundred and seventy one of 271 infants were alive on discharge (63.1%), 37 of 271 were stillborn (13.6%), and 44 of 271 were expired on discharge, (16.2%)—42 of the 44 neonatal deaths occurred in preterm deliveries (95.5%) and 2 of 44 neonatal deaths occurred in term deliveries (4.5%).

3.3. Correlation of Risk Factors for Placental Abruption with Neonatal and Maternal Morbidity and Mortality

Cesarean section as mode of delivery was statistically significantly associated with poor neonatal outcome (p = 0.018 and p = 0.015) in the univariate analysis (Table 1). A lower gestational age was associated with increased neonatal morbidity and mortality via univariate and multivariate analysis (p < 0.001 in both) (Table 1). The ROC curve analysis showed a significant increase of neonatal risk below 31 weeks of gestation (AUC 0.743, p < 0.001) (Figure 1). Crack/cocaine use was associated with poor maternal outcome via univariate and multivariate analysis (p = 0.033 and p = 0.015) (Table 2). HELLP syndrome and having a history of previous cesarean delivery were correlated with maternal morbidity and mortality (p = 0.017 and p = 0.047) using the multivariate analysis (Table 2).
PPROM was associated with a better neonatal outcome in the univariate analysis (p = 0.018) and preeclampsia was associated with a better maternal outcome in the multivariate analysis (p = 0.029) (Table 2).

4. Discussion

Placental abruption is rapidly increasing in the USA with a significant portion of abruptions occurring in African American women [2,3]. Placental abruption is a leading cause of obstetric hemorrhage and perinatal death—20% of all fetal deaths from abruption occur after presenting to a hospital with 30% of those deaths occurring within 2 h of admission [1,23]. In one study approximately 40–60% of placental abruption occur before 37 weeks of gestation; the incidence of placental abruption peaks between 24 and 26 weeks [10,14].
The exact cause of placental abruption is unknown—a prevalent hypothesis indicates that placental abruption is secondary to vascular malformations and fragile vasculature resulting in hematoma formation and ultimately placental separation [10]. Approximately 10% of all preterm births occur because of abruption and are associated with increased rates periventricular leukomalacia and intraventricular hemorrhage [10,24]. Placental abruption leads to a decrease in placental surface area necessary for oxygenation, ultimately leading to increased fetal morbidity and mortality [25]. Risk factors such as hypertensive disorders of pregnancy, cocaine use, alcohol use, trauma, cigarette smoking, prior history of placental abruption, and PPROM have all been associated with placental abruption [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17]. However, our findings indicate that these established risk factors do not correlate with poor neonatal outcomes in African American women. Our results indicate that gestational age of less than 31 weeks and mode of delivery via cesarean section were the only risk factors statistically significant for increased neonatal morbidity and mortality via univariate analysis. A gestational age lower than 31 weeks was the only risk factor significantly associated with neonatal risk in the multivariate analysis.
Only crack/cocaine use was associated with maternal increased maternal morbidity and mortality in the univariate analysis. HELLP syndrome, history of a previous cesarean delivery and crack/cocaine use were statistically significantly associated with increased maternal morbidity and mortality using the multivariate analysis.
PPROM appears to be protective for the neonatal outcome in the univariate analysis, and preeclampsia appears to be protective for maternal outcome in the multivariate analysis. The clinical value of these latter findings is less obvious, and we speculate that the diagnosis of PPROM/preeclampsia may have helped towards a promptly diagnosis of placental abruption and therefore to a quicker and safer delivery.
Limitations of our study were its retrospective nature and the time frame, it ended in 1996 so it is not the most current. In addition, we did not record the data regarding a previous occurrence of placental abruption.
A strength of the study is the belonging of the whole cohort of patients to a single center study, making the study group less heterogeneous.

5. Conclusions

Low gestational age at delivery is the most important risk factor for poor neonatal outcome in African American women with placental abruption. HELLP syndrome, crack/cocaine use and previous cesarean section correlated with poor maternal outcome. More research in this understudied population is needed to establish a reliable risk factor pattern and coordinate preventive interventions.

Author Contributions

Conceptualization, D.E. and A.K.; methodology, A.K.; software, J.M.; validation, G.S., B.R.E. and D.E.; formal analysis, J.M.; investigation, D.E.; resources, D.E.; data curation, G.S.; writing—original draft preparation, D.E.; writing—review and editing, G.S.; visualization, S.A.; supervision, A.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Pritchard, J.A. Genesis of severe placental abruption. Am. J. Obstet. Gynecol. 1970, 108, 22–27. [Google Scholar] [CrossRef]
  2. Ananth, C.V.; Lavery, J.A.; Vintzileos, A.M.; Skupski, D.W.; Varner, M.W.; Saade, G.; Biggio, J.R.; Williams, M.A.; Wapner, R.J.; Wright, J.D. Severe placental abruption: Clinical definition and associations with maternal complications. Am. J. Obstet. Gynecol. 2016, 214, e1–e9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Ananth, C.V.; Oyelese, Y.; Yeo, L.; Pradhan, A.; Vintzileos, A.M. Placental abruption in the United States, 1979 through 2001: Temporal trends and potential determinants. Am. J. Obstet. Gynecol. 2005, 192, 191–198. [Google Scholar] [CrossRef] [PubMed]
  4. Pariente, G.; Wainstock, T.; Walfisch, A.; Landau, D.; Sheiner, E. Placental abruption and long-term neurological hospitalisations in the offspring. Paediatr. Perinat. Epidemiol. 2019, 33, 215–222. Available online: https://www.ncbi.nlm.nih.gov/pubmed/31131918. [CrossRef] [PubMed]
  5. Li, Y.; Tian, Y.; Liu, N.; Chen, Y.; Wu, F. Analysis of 62 placental abruption cases: Risk factors and clinical outcomes. Taiwan J. Obstet. Gynecol. 2019, 58, 223–226. Available online: https://www.ncbi.nlm.nih.gov/pubmed/30910143. [CrossRef] [PubMed]
  6. Rasmussen, S.; Irgens, L.M.; Bergsjø, P.; Dalaker, K. The occurrence of placental abruption in Norway 1967–1991. Acta Obstet. Gynecol. Scand. 1996, 75, 222–228, IUGR. [Google Scholar] [CrossRef]
  7. Naeyes, R.L.; Harkness, W.L.; Utts, J. Abruption placentae and perinatal death: A prospective study. Am. J. Obstet. Gynecol. 1977, 128, 740–746, IUGR. [Google Scholar] [CrossRef]
  8. Hibbard, B.M.; Jeffcoate, T.N. Abruptio Placenta. Obstet. Gynecol. 1966, 27, 155–167, IUGR + GENERAL RISK FACTORS. [Google Scholar]
  9. Linqvist, P.G.; Happach, C. Risk and risk estimation of placental abruption. Obstet. Gynecol. Reprod. Biol. 2006, 126, 160–164, GENERAL RISK FACTORS. [Google Scholar] [CrossRef] [Green Version]
  10. Oyelese, Y.; Ananth, C.V. Placental abruption. Obstet. Gynecol. 2006, 108, 1005–1016, GENERAL RISK FACTORS INCLUDING PRIOR ABRUPTION. [Google Scholar] [CrossRef]
  11. Sheiner, E.; Shoham-Vardi, I.; Hallak, M.; Hadar, A.; Gortzak-Uzan, L.; Katz, M.; Mazor, M. Placental abruption in term pregnancies: Clinical significance and obstetric risk factors. J. Matern. Fetal. Neonatal. 2003, 13, 45–49. [Google Scholar] [CrossRef]
  12. Toivonen, S.; Anttila, M.; Heinonen, S.; Kosma, V.M.; Saarikoski, S. Obstetric Prognosis after Placental Abruption. Fetal Diagn. Ther. 2004, 19, 336–341, RECURRENCE AND OB AND FETAL OUTCOME. [Google Scholar] [CrossRef] [PubMed]
  13. Hoskins, I.A.; Friedman, D.M.; Frieden, F.J.; Ordorica, S.A.; Young, B.K. Relationship between antepartum cocaine abuse, abnormal umbilical artery Doppler velocimetry, and placental abruption. Obstet. Gynecol. 1991, 78, 279–282, HISTORY OF PLACENTAL ABRUPTION. [Google Scholar] [PubMed]
  14. Tikkanen, M. Placental abruption: Epidemiology, risk factors and consequences. Acta Obstet. Gynecol. Scand. 2011, 90, 140–149, RISK WITH SUPERIMPOSED PEC. [Google Scholar] [CrossRef] [PubMed]
  15. Cnattingius, S. Maternal Age Modifies the Effect of Maternal Smoking on Intrauterine Growth Retardation but Not on Late Fetal Death and Placental Abruption. Am. J. Epidemiol. 1997, 145, 319–323. [Google Scholar] [CrossRef] [Green Version]
  16. Castles, A.; Adams, E.K.; Melvin, C.L.; Kelsch, C.; Boulton, M.L. Effects of smoking during pregnancy. Five meta-analyses. Am. J. Prev. Med. 1999, 16, 208–215. [Google Scholar] [CrossRef]
  17. Ananth, C.V.; Savitz, D.A.; Luther, E.R. Maternal Cigarette Smoking as a Risk Factor for Placental Abruption, Placenta Previa, and Uterine Bleeding in Pregnancy. Am. J. Epidemiol. 1996, 144, 881–889. [Google Scholar] [CrossRef] [Green Version]
  18. Ananth, C.V. Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy: A meta-analysis of observational studies. Obstet. Gynecol. 1999, 93, 622–628. [Google Scholar] [CrossRef]
  19. Placental abruption- March of Dimes. Available online: .https://www.marchofdimes.org/complications/placental-abruption.aspx# (accessed on 8 April 2020).
  20. Carvalho, W.B.; Matsushita, F.Y.; Krebs, V.L.J. Gray zone: Mortality profile of newborns at the limit of viability. Rev. Assoc. Med. Bras. (1992) 2019, 65, 1128–1129. [Google Scholar] [CrossRef]
  21. American College of Obstetrician and Gynecologists. Committee Opinion No. 700. Methods for Estimating the Due Date. Obstet. Gynecol. 2017, 129, 150–154. [Google Scholar] [CrossRef]
  22. American College of Obstetricians and Gynecologists. Practice Bulletin No. 183. Postpartum Hemorrhage. Obstet. Gynecol. 2017, 130, 168–186. [Google Scholar] [CrossRef] [PubMed]
  23. Knab, D.R. Abruptio placentae. An assessment of the time and method of delivery. Obstet. Gynecol. 1978, 52, 625–629. [Google Scholar] [PubMed]
  24. Gibbs, J.M.; Weindling, A.M. Neonatal intracranial lesions following placental abruption. Eur. J. Pediatr. 1994, 153, 195–197. [Google Scholar] [CrossRef] [PubMed]
  25. Morgan, K.; Arulkumaran, S. Antepartum haemorrhage. Curr. Obstet. Gynaecol. 2003, 13, 81–87. [Google Scholar] [CrossRef]
Figure 1. Receiver operating characteristic (ROC) curve of the association between gestational age at delivery/placental abruption and neonatal outcome. Area under the curve (AUC): 0.743; p < 0.001.
Figure 1. Receiver operating characteristic (ROC) curve of the association between gestational age at delivery/placental abruption and neonatal outcome. Area under the curve (AUC): 0.743; p < 0.001.
Medicina 56 00174 g001
Table 1. Risk factors and their association with neonatal outcome.
Table 1. Risk factors and their association with neonatal outcome.
VariablesPoor Neonatal Outcome
n = 237
Good Neonatal Outcome
n = 35
p-Value *p-Value **
Preeclampsia58/237 (24%)8/35 (22.8%)NSNS
Eclampsia3/237 (1.2%)0/35 (0%)NSNS
HELLP11/237 (4.6%)2/35 (5.7%)NSNS
CHTN14/237 (5.9%)1/35 (2.8%)NSNS
PROM2/237 (0.8%)1/35 (2.8%)NSNS
PPROM73/237 (3%)4/35 (11.4%)0.018NS
Mechanical trauma4/237 (1.6%)1/35 (2.8%)NSNS
Crack/cocaine38/237 (16%)6/35 (17.1%)NSNS
Smoking55/237 (23.2%)4/35 (11.4%)NSNS
Alcohol42/237 (17.7%)6/35 (17.1%)NSNS
Placenta previa7/237 (2.9%)2/35 (5.7%)NSNS
GDM9/237 (3.7%)1/35 (2.8%)NSNS
PreGDM1/237 (0.4%)0/35 (0%)NSNS
Previous c section40/237 (16.8%)4/35 (11.4%)NSNS
IUGR5/237 (2.1%)0/35 (0%)NSNS
Gravidity > 157/237 (24%)24/35 (68.5%)NSNS
Parity > 0164/237 (56.5%)22/35 (62.8%)NSNS
Mode of delivery
(c section/total)
152/237 (64.1%)15/35 (42.8%)0.015NS
Age (years)24 (20–29)25 (21–31.75)NSNS
GA at delivery (weeks)31 (26.8–35)35.5 (33–38.7)<0.001<0.001
Categorical variables are shown as ratio (%); continuous variables are shown as median (25°–75° percentile). * Chi square test for categorical variables and Mann-Whitney test for continuous variables. ** Multivariate logistic regression analysis. Hemolysis, elevated enzymes, low platelet (HELLP), chronic hypertension (CHTN). premature rupture of membranes (PROM). preterm premature rupture of membranes (PPROM), gestational diabetes mellitus (GDM), intrauterine growth retardation (IUGR), cesarean section (c section), gestational age (GA), not significant (NS).
Table 2. Risk factors and their association with poor maternal outcome.
Table 2. Risk factors and their association with poor maternal outcome.
VariablesPoor Maternal Outcome
n = 26
Good Maternal Outcome
n = 246
p-Value *p-Value **
Preeclampsia4/26 (15.3%)62/246 (25.2%)NS0.029
Eclampsia0/26 (0%)3/246 (1.2%)NSNS
HELLP3/26 (11.5%)10/246 (2.8%)NS0.017
CHTN1/26 (3.8%)14/246 (5.6%)NSNS
PROM0/26 (0%)3/246 (1.2%)NSNS
PPROM7/26 (26.9%)70/246 (28.4%)NSNS
Mechanical trauma0/26 (0%)5/246 (2%)NSNS
Crack/cocaine8/26 (30.7%)36/246 (14.6%)0.0330.015
Smoking9/26 (34.6%)50/246 (20.3%)NSNS
Alcohol7/26 (26.9%)41/245 (16.7%)NSNS
Placenta previa0/26 (0%)9/246 (3.6%)NSNS
GDM1/26 (3.8%)9/246 (3.6%)NSNS
PreGDM0/26 (0%)1/246 (0.4%)NSNS
Previous c section6/26 (23%)38/246 (15.4%)NS0.047
IUGR0/26 (0%)5/246 (2%)NSNS
Gravidity > 116/26 (61.5%)188/246 (76.4%)NSNS
Parity > 016/26 (61.5%)170/246 (69.1%)NSNS
Mode of delivery
(c section/total)
15/26 (57.6%)152/246 (61.7%)NSNS
Age (years)27 (21–30)23 (20–29)NSNS
GA at delivery (weeks)32 (26–34)32 (27–36)NSNS
Categorical variables are shown as ratio (%); continuous variables are shown as median (25°–75° percentile). * Chi square test. ** Multivariate logistic regression analysis. Hemolysis, elevated enzymes, low platelet (HELLP), chronic hypertension (CHTN), preterm premature rupture of membranes (PPROM), premature rupture of membranes (PROM), gestational diabetes mellitus (GDM), intrauterine growth retardation (IUGR), cesarean section (c section), gestational age (GA), not significant (NS).

Share and Cite

MDPI and ACS Style

Elkafrawi, D.; Sisti, G.; Araji, S.; Khoury, A.; Miller, J.; Rodriguez Echevarria, B. Risk Factors for Neonatal/Maternal Morbidity and Mortality in African American Women with Placental Abruption. Medicina 2020, 56, 174. https://doi.org/10.3390/medicina56040174

AMA Style

Elkafrawi D, Sisti G, Araji S, Khoury A, Miller J, Rodriguez Echevarria B. Risk Factors for Neonatal/Maternal Morbidity and Mortality in African American Women with Placental Abruption. Medicina. 2020; 56(4):174. https://doi.org/10.3390/medicina56040174

Chicago/Turabian Style

Elkafrawi, Deena, Giovanni Sisti, Sarah Araji, Aldo Khoury, Jacob Miller, and Brian Rodriguez Echevarria. 2020. "Risk Factors for Neonatal/Maternal Morbidity and Mortality in African American Women with Placental Abruption" Medicina 56, no. 4: 174. https://doi.org/10.3390/medicina56040174

APA Style

Elkafrawi, D., Sisti, G., Araji, S., Khoury, A., Miller, J., & Rodriguez Echevarria, B. (2020). Risk Factors for Neonatal/Maternal Morbidity and Mortality in African American Women with Placental Abruption. Medicina, 56(4), 174. https://doi.org/10.3390/medicina56040174

Article Metrics

Back to TopTop